Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT00601172
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
- Locations
-
- GSK Investigational Site Hot Springs, Arkansas, United States
- GSK Investigational Site Corona, California, United States
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Riverside, California, United States
NCT00437229
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
NCT01449188
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
NCT00404378
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Lenexa, Kansas, United States
NCT00405080
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Tacoma, Washington, United States
NCT00404274
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Gainesville, Florida, United States
- GSK Investigational Site Buffalo, New York, United States
Completed
The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
NCT00440128
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Hot Springs, Arkansas, United States
- GSK Investigational Site Iowa City, Iowa, United States
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Lebanon, New Hampshire, United States
NCT00460707
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
- GSK Investigational Site Buffalo, New York, United States
- GSK Investigational Site Columbus, Ohio, United States
NCT00511823
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Evansville, Indiana, United States
NCT00104403
- Conditions
- Chemotherapy-induced Nausea and Vomiting, Nausea, Nausea and Vomiting, Chemotherapy-Induced, +4 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Corona, California, United States
- GSK Investigational Site Greenbrae, California, United States
- GSK Investigational Site Loma Linda, California, United States
NCT00366834
- Conditions
- Nausea, Nausea and Vomiting, Chemotherapy-Induced, Pathological Conditions, Signs and Symptoms, +3 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Glendale, Arizona, United States
- GSK Investigational Site Fayetteville, Arkansas, United States